Piotech (688072) 国投证券·2025-04-25 14:31Investment Rating - The investment rating for the company is "Buy-A" with a target price of 192.67 CNY per share [6]. Core Views - The company has a strong order backlog of 9.4 billion CNY, which supports long-term growth. The revenue growth in 2024 is primarily driven by the ramp-up of new products and processes [2]. - The company achieved a revenue of 4.103 billion CNY in 2024, representing a year-on-year increase of 51.7%. The net profit attributable to shareholders was 688 million CNY, up 3.86% year-on-year [1][2]. - The gross margin for 2024 was 41.69%, down 9.32 percentage points year-on-year, indicating short-term pressure on profitability due to increased R&D investments and high costs associated with new product validation [2]. Summary by Sections Financial Performance - In Q4 2024, the company reported revenue of 1.826 billion CNY, a year-on-year increase of 82.11%, and a net profit of 417 million CNY, up 6.46% year-on-year [1]. - The company’s R&D expenses reached 756 million CNY in 2024, a 31.26% increase year-on-year, reflecting a commitment to innovation [2]. Product Development - The company’s thin film deposition equipment generated revenue of 3.863 billion CNY in 2024, a 50.29% increase year-on-year, with significant production stability [3]. - Advanced bonding equipment and related detection devices contributed 96 million CNY in revenue, up 48.78% year-on-year, with successful customer validations for new products [4]. Future Projections - Revenue projections for 2025, 2026, and 2027 are 5.417 billion CNY, 6.933 billion CNY, and 8.458 billion CNY, respectively, with net profits expected to be 998 million CNY, 1.413 billion CNY, and 1.947 billion CNY [9][10].